Iron overload and Neoplasm progression
Summary:
Neoplasm progression is found among people with Iron overload, especially for people who are male, 60+ old.
The study analyzes which people have Neoplasm progression with Iron overload. It is created by eHealthMe based on reports of 68 people who have Iron overload from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Iron overload?
Iron overload is found to be associated with 199 drugs and 311 conditions by eHealthMe. Check the latest studies of Iron overload.
What is Neoplasm progression?
Neoplasm progression (growth of tumour) is found to be associated with 1,069 drugs and 912 conditions by eHealthMe. Check the latest studies of Neoplasm progression.
68 people who have Iron Overload and Neoplasm Progression are studied.

Gender of people who have Iron Overload and experienced Neoplasm Progression *:
- female: 32.84 %
- male: 67.16 %
Age of people who have Iron Overload and experienced Neoplasm Progression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 7.14 %
- 40-49: 0.0 %
- 50-59: 10.71 %
- 60+: 82.14 %
Common co-existing conditions for these people *:
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 16 people, 23.53%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 11.76%
- Insomnia (sleeplessness): 5 people, 7.35%
- Pneumonia: 5 people, 7.35%
- Pain: 3 people, 4.41%
- Haemochromatosis (body to absorb more iron than usual from food): 3 people, 4.41%
- Neuropathy Peripheral (surface nerve damage): 3 people, 4.41%
- High Blood Pressure: 3 people, 4.41%
- Cerebral Infarction (less blood supply to brain resulting tissue damage): 2 people, 2.94%
- Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 2 people, 2.94%
Common drugs taken by these people *:
- Exjade: 65 people, 95.59%
- Lasix: 13 people, 19.12%
- Neoral: 10 people, 14.71%
- Hydrea: 9 people, 13.24%
- Itraconazole: 8 people, 11.76%
- Diflucan: 7 people, 10.29%
- Famotidine: 7 people, 10.29%
- Zolpidem: 7 people, 10.29%
- Lansoprazole: 7 people, 10.29%
- Allopurinol: 7 people, 10.29%
Common symptoms for these people *:
- Neoplasm Malignant (cancer tumour): 53 people, 77.94%
- Fever: 20 people, 29.41%
- Pneumonia: 13 people, 19.12%
- Anaemia (lack of blood): 13 people, 19.12%
- Renal Impairment (severely reduced kidney function): 12 people, 17.65%
- Nausea (feeling of having an urge to vomit): 10 people, 14.71%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 9 people, 13.24%
- Blood Creatinine Increased: 8 people, 11.76%
- White Blood Cell Count Decreased: 8 people, 11.76%
- Hepatic Function Abnormal: 8 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Neoplasm progression?
- Check whether Neoplasm progression is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Iron overload (10,704 reports)
- Neoplasm progression (41,778 reports)
All the drugs that are associated with Neoplasm progression:
- Neoplasm progression (1,069 drugs)
All the conditions that are associated with Neoplasm progression:
- Neoplasm progression (912 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Neoplasm progression and Iron overload, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Simethicone cause Post Procedural Complication? - 38 seconds ago
- Could Omnaris cause Idiopathic Pulmonary Fibrosis? - 44 seconds ago
- Could Lutein cause Gastric Ulcer? - 44 seconds ago
- Hallucinations Aggravated and Abdominal Pain Upper - 50 seconds ago
- Could Ethyol cause Chest Pain? - 57 seconds ago
- Could Sildenafil Citrate cause Middle Insomnia? - 59 seconds ago
- Drug interactions of Silodosin and Celecoxib - 59 seconds ago
- Could Lupron cause Haematoma? - a minute ago
- Could Metoprolol Tartrate cause Hepatic Enzyme Abnormal? - a minute ago
- Could Flucytosine cause Sepsis? - a minute ago